Agilent Technologies, Inc. (A) has a MoatMap StockRank of 57/100 based on Quality (69/100), Value (33/100), and Momentum (39/100) factor scores. The current signal is HOLD. Agilent Technologies is a high-quality business (Q: 64) with strong moats in scientific instruments and diagnostics, aligning with the 'Durable Quality & Moats' theme. However, it lacks a *specific, unpriced macro inflection point* from our identified themes that would create an asymmetric opportunity within the 18-month horizon, making it a good 'buy and hold' but not a high-conviction macro play.
Agilent Technologies, Inc. is a global leader in life sciences, diagnostics, and applied chemical markets, providing analytical instruments, software, services, and consumables. Its competitive advantage stems from its comprehensive portfolio of high-precision scientific tools and strong R&D capabilities that serve critical research and quality control functions. Agilent operates as a key enabler for advancements in pharmaceuticals, food safety, environmental analysis, and diagnostics worldwide.
| Price | $135.38 |
| Market Cap | $32.5B |
| P/E (TTM) | 25.40 |
| P/E (Forward) | 17.57 |
| Price/Book | 4.71 |
| Return on Equity | 19.9% |
| Return on Invested Capital | 14.9% |
| Debt/Equity | 51.39 |
| Gross Margin | 52.3% |
| Operating Margin | 22.9% |
| Revenue Growth | 7.0% |
| Dividend Yield | 0.9% |
| Free Cash Flow | $856M |
Agilent Technologies, Inc. operates in the Diagnostics & Research industry, part of the Healthcare sector (United States).